Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110575143 | 11057514 | 3 | F | 20140412 | 20160823 | 20150422 | 20160829 | EXP | MX-ALLERGAN-1507232US | ALLERGAN | 45.00 | YR | F | Y | 85.00000 | KG | 20160829 | MD | ES | MX |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110575143 | 11057514 | 1 | PS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | 53 UNITS, SINGLE | C3292 | 103000 | POWDER FOR INJECTION | QD | |||||||
| 110575143 | 11057514 | 2 | SS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | 3 UNITS, SINGLE | 103000 | POWDER FOR INJECTION | QD | ||||||||
| 110575143 | 11057514 | 3 | SS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | 9 UNITS, SINGLE | 103000 | POWDER FOR INJECTION | QD | ||||||||
| 110575143 | 11057514 | 4 | SS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | 2 UNITS, SINGLE | 103000 | POWDER FOR INJECTION | QD | ||||||||
| 110575143 | 11057514 | 5 | SS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | 7 UNITS, SINGLE | 103000 | POWDER FOR INJECTION | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110575143 | 11057514 | 1 | Skin wrinkling |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110575143 | 11057514 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110575143 | 11057514 | Atrophy | |
| 110575143 | 11057514 | Body temperature increased | |
| 110575143 | 11057514 | Granuloma skin | |
| 110575143 | 11057514 | Mycobacterial infection | |
| 110575143 | 11057514 | Off label use | |
| 110575143 | 11057514 | Papule | |
| 110575143 | 11057514 | Rash papular |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110575143 | 11057514 | 1 | 20140412 | 20140412 | 0 | |
| 110575143 | 11057514 | 2 | 20140412 | 20140412 | 0 | |
| 110575143 | 11057514 | 3 | 20140412 | 20140412 | 0 | |
| 110575143 | 11057514 | 4 | 20140412 | 20140412 | 0 | |
| 110575143 | 11057514 | 5 | 20140412 | 20140412 | 0 |